{"entity":{"type":"insider","cik":"0001420766","url":"/insider/0001420766","json_url":"/insider/0001420766.json","name":"Nicholson John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":19,"first":"2015-08-13","last":"2019-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Nicholson John","source":"filing","n_filings":19,"first_seen":"2015-08-13","last_seen":"2019-08-19"}],"transactions":[{"id":8759393,"accession":"0001209191-19-046718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046718","line_url":"/filing/0001209191-19-046718#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3819.0,"shares_display":"3,819","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":69314.85,"total_display":"69,314.85","total_whole":"69,315","shares_owned_after":162759.0,"shares_owned_after_display":"162,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-19","scope":"insider"},{"id":7840573,"accession":"0001209191-19-031188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-031188","line_url":"/filing/0001209191-19-031188#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4077.0,"shares_display":"4,077","price_per_share":31.37,"price_display":"31.37","price_state":"stated","total_value":127895.49,"total_display":"127,895.49","total_whole":"127,895","shares_owned_after":166578.0,"shares_owned_after_display":"166,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-17","scope":"insider"},{"id":8117702,"accession":"0001209191-19-012335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-012335","line_url":"/filing/0001209191-19-012335#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3822.0,"shares_display":"3,822","price_per_share":42.39,"price_display":"42.39","price_state":"stated","total_value":162014.58,"total_display":"162,014.58","total_whole":"162,015","shares_owned_after":170655.0,"shares_owned_after_display":"170,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"},{"id":8526298,"accession":"0001209191-19-006044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-006044","line_url":"/filing/0001209191-19-006044#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63000.0,"shares_display":"63,000","price_per_share":42.82,"price_display":"42.82","price_state":"stated","total_value":2697660.0,"total_display":"2,697,660.00","total_whole":"2,697,660","shares_owned_after":174477.0,"shares_owned_after_display":"174,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-28","filed_date":"2019-01-30","scope":"insider"},{"id":6021750,"accession":"0001209191-18-059293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-059293","line_url":"/filing/0001209191-18-059293#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5982.0,"shares_display":"5,982","price_per_share":38.25,"price_display":"38.25","price_state":"stated","total_value":228811.5,"total_display":"228,811.50","total_whole":"228,812","shares_owned_after":174477.0,"shares_owned_after_display":"174,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-19","scope":"insider"},{"id":6862079,"accession":"0001209191-18-031596","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-031596","line_url":"/filing/0001209191-18-031596#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4917.0,"shares_display":"4,917","price_per_share":83.39,"price_display":"83.39","price_state":"stated","total_value":410028.63,"total_display":"410,028.63","total_whole":"410,029","shares_owned_after":162596.0,"shares_owned_after_display":"162,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-18","scope":"insider"},{"id":6331861,"accession":"0001209191-18-018221","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-018221","line_url":"/filing/0001209191-18-018221#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100144.0,"shares_display":"100,144","price_per_share":100.45,"price_display":"100.45","price_state":"stated","total_value":10059464.8,"total_display":"10,059,464.80","total_whole":"10,059,465","shares_owned_after":167513.0,"shares_owned_after_display":"167,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-07","filed_date":"2018-03-08","scope":"insider"},{"id":6331858,"accession":"0001209191-18-018221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-018221","line_url":"/filing/0001209191-18-018221#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":98.29,"price_display":"98.29","price_state":"stated","total_value":11794800.0,"total_display":"11,794,800.00","total_whole":"11,794,800","shares_owned_after":267657.0,"shares_owned_after_display":"267,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-08","scope":"insider"},{"id":6657591,"accession":"0001209191-18-011595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-011595","line_url":"/filing/0001209191-18-011595#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4879.0,"shares_display":"4,879","price_per_share":82.94,"price_display":"82.94","price_state":"stated","total_value":404664.26,"total_display":"404,664.26","total_whole":"404,664","shares_owned_after":387657.0,"shares_owned_after_display":"387,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-20","scope":"insider"},{"id":4114273,"accession":"0001209191-17-060974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-060974","line_url":"/filing/0001209191-17-060974#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15910.0,"shares_display":"15,910","price_per_share":37.78,"price_display":"37.78","price_state":"stated","total_value":601079.8,"total_display":"601,079.80","total_whole":"601,080","shares_owned_after":233156.0,"shares_owned_after_display":"233,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-15","scope":"insider"},{"id":4084491,"accession":"0001209191-17-049667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-049667","line_url":"/filing/0001209191-17-049667#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3177.0,"shares_display":"3,177","price_per_share":19.32,"price_display":"19.32","price_state":"stated","total_value":61379.64,"total_display":"61,379.64","total_whole":"61,380","shares_owned_after":224066.0,"shares_owned_after_display":"224,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-18","scope":"insider"},{"id":4627745,"accession":"0001209191-17-038973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-038973","line_url":"/filing/0001209191-17-038973#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101700.0,"shares_display":"101,700","price_per_share":19.24,"price_display":"19.24","price_state":"stated","total_value":1956708.0,"total_display":"1,956,708.00","total_whole":"1,956,708","shares_owned_after":227243.0,"shares_owned_after_display":"227,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-07","filed_date":"2017-06-09","scope":"insider"},{"id":4831281,"accession":"0001209191-17-033770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033770","line_url":"/filing/0001209191-17-033770#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3146.0,"shares_display":"3,146","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":61504.3,"total_display":"61,504.30","total_whole":"61,504","shares_owned_after":178943.0,"shares_owned_after_display":"178,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-18","scope":"insider"},{"id":4195047,"accession":"0001209191-17-012407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-012407","line_url":"/filing/0001209191-17-012407#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3237.0,"shares_display":"3,237","price_per_share":13.14,"price_display":"13.14","price_state":"stated","total_value":42534.18,"total_display":"42,534.18","total_whole":"42,534","shares_owned_after":182089.0,"shares_owned_after_display":"182,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":4604148,"accession":"0000899243-17-002871","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-002871","line_url":"/filing/0000899243-17-002871#line-4","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8505.0,"shares_display":"8,505","price_per_share":12.48,"price_display":"12.48","price_state":"stated","total_value":106142.4,"total_display":"106,142.40","total_whole":"106,142","shares_owned_after":140326.0,"shares_owned_after_display":"140,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-06","scope":"insider"},{"id":4604139,"accession":"0000899243-17-002871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-002871","line_url":"/filing/0000899243-17-002871#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66495.0,"shares_display":"66,495","price_per_share":12.38,"price_display":"12.38","price_state":"stated","total_value":823208.1,"total_display":"823,208.10","total_whole":"823,208","shares_owned_after":140326.0,"shares_owned_after_display":"140,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-02","filed_date":"2017-02-06","scope":"insider"},{"id":2792873,"accession":"0001209191-16-151304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151304","line_url":"/filing/0001209191-16-151304#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1654.0,"shares_display":"1,654","price_per_share":13.96,"price_display":"13.96","price_state":"stated","total_value":23089.84,"total_display":"23,089.84","total_whole":"23,090","shares_owned_after":120326.0,"shares_owned_after_display":"120,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-18","scope":"insider"},{"id":2109266,"accession":"0001209191-16-137615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-137615","line_url":"/filing/0001209191-16-137615#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3317.0,"shares_display":"3,317","price_per_share":17.56,"price_display":"17.56","price_state":"stated","total_value":58246.52,"total_display":"58,246.52","total_whole":"58,247","shares_owned_after":121980.0,"shares_owned_after_display":"121,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-17","scope":"insider"},{"id":2885688,"accession":"0001209191-16-121365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-121365","line_url":"/filing/0001209191-16-121365#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":856.0,"shares_display":"856","price_per_share":13.58,"price_display":"13.58","price_state":"stated","total_value":11624.48,"total_display":"11,624.48","total_whole":"11,624","shares_owned_after":77630.0,"shares_owned_after_display":"77,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-17","filed_date":"2016-05-18","scope":"insider"},{"id":2406049,"accession":"0001209191-16-100218","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-100218","line_url":"/filing/0001209191-16-100218#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":963.0,"shares_display":"963","price_per_share":11.92,"price_display":"11.92","price_state":"stated","total_value":11478.96,"total_display":"11,478.96","total_whole":"11,479","shares_owned_after":76319.0,"shares_owned_after_display":"76,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-18","scope":"insider"},{"id":8542017,"accession":"0001209191-15-065872","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-15-065872","line_url":"/filing/0001209191-15-065872","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69976.0,"shares_display":"69,976","price_per_share":10.479659311764033,"price_display":"10.48","price_state":"stated","total_value":733324.64,"total_display":"733,324.64","total_whole":"733,325","shares_owned_after":75116.0,"shares_owned_after_display":"75,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2015-08-13","scope":"insider","n_lines":2},{"id":8542002,"accession":"0001209191-15-065872","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-065872","line_url":"/filing/0001209191-15-065872","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001420766","owner_name":"Nicholson John","owner_display_name":"Nicholson John","owner_url":"/insider/0001420766","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249908.0,"shares_display":"249,908","price_per_share":10.86835523472638,"price_display":"10.87","price_state":"stated","total_value":2716088.92,"total_display":"2,716,088.92","total_whole":"2,716,089","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-13","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Officer (SVP & Chief Operating Officer)","n_filings":19,"first_seen":"2015-08-13","last_seen":"2019-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001420766","retrieved_at":"2026-08-23T05:47:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}